Fate Therapeutics Reports First Quarter 2023 Financial Results and Business UpdatesGlobeNewsWire • 05/03/23
Fate Therapeutics (FATE) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 05/03/23
Fate Therapeutics (FATE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseZacks Investment Research • 04/26/23
Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2023 Financial ResultsGlobeNewsWire • 04/24/23
Why Is Fate Therapeutics (FATE) Down 8.9% Since Last Earnings Report?Zacks Investment Research • 03/30/23
FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fate Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important March 22 Deadline in Securities Class Action – FATEBusiness Wire • 03/22/23
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (NASDAQ: FATE)PRNewsWire • 03/22/23
FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 03/21/23
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fate Therapeutics, Inc. (FATE)Business Wire • 03/21/23
FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. ShareholdersPRNewsWire • 03/21/23
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fate Investors of a Lead Plaintiff Deadline of March 22, 2023PRNewsWire • 03/20/23
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Fate Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important March 22 Deadline in Securities Class Action - FATEPRNewsWire • 03/18/23
FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud LawsuitPRNewsWire • 03/17/23
FATE SHAREHOLDER ALERT: Jakubowitz Law Reminds Fate Shareholders of a Lead Plaintiff Deadline of March 22, 2023PRNewsWire • 03/17/23
FATE LAWSUIT ALERT: Levi & Korsinsky Notifies Fate Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 03/16/23
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATEPRNewsWire • 03/13/23
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important March 22 Deadline in Securities Class Action - FATEPRNewsWire • 03/11/23
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATEPRNewsWire • 03/04/23
Fate Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business UpdatesGlobeNewsWire • 02/28/23
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FATEPRNewsWire • 02/25/23